Article

Ernest Beutler: his life and contribution to medical science.

Redlands Community Hospital, Redlands, CA, USA.
British Journal of Haematology (Impact Factor: 4.94). 03/2011; 152(5):543-50. DOI: 10.1111/j.1365-2141.2010.08542.x
Source: PubMed

ABSTRACT Ernest Beutler was one of the preeminent haematologists of the last half of the 20th and the early 21st century. In a career that spanned six decades, his research interests included such diverse areas as red cell metabolism, blood preservation, glycolipid storage diseases, leukaemias and iron metabolism. Indeed, he was quite different from most of his contemporaries in that his knowledge encompassed not only haematology and not only the medical sciences, but the biological sciences as a whole. He was among the first to describe X chromosome inactivation, and he established the critical link between glucose-6-phosphate dehydrogenase deficiency and drug-induced haemolysis. He was a skilled and innovative clinician, and an early advocate of bone marrow transplantation for the treatment of acute leukaemia. He was a prolific author, with over 800 publications; a long time member of the Editorial Board of Blood; founder of the journal Blood Cells Molecules and Diseases; and an editor of Williams Haematology from the time of its inception. He bequeathed $1 million to the American Society of Haematology to recognise and reward outstanding basic research and its clinical application: a pursuit to which he had committed his life. Indeed, he became an extraordinary exemplar of the bench-to-bedside ethos, which holds that even today, an MD researcher, working with limited means and independent of pharmaceutical companies, can have a great impact on the practice of medicine.

0 Bookmarks
 · 
99 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Tay-Sachs disease and related GM2 ganglioside storage disorders result from the absence of one form of hexosaminidase, HEX A. The persistence of a second major hexosaminidase isozyme, HEX B, does not protect against the lethal accumulation of GM2 ganglioside in the central nervous system. Using immunologic and biochemical techniques, it has been demonstrated that the two major isozymes of hexosaminidase, HEX A and HEX B, share a common subunit, the structure of HEX A being designated (alpha beta)n and the structure of HEX B being designated as (beta2)n. The minor isozyme, HEX S, is an alpha chain homopolymer designated (alpha2)n, and HEX C seems unrelated to the HEX A, B, S system. The structures of other minor isozymes have not been totally resolved, but HEX I1, I2, and P (which may be identical to I2) appear to represent forms of HEX B.
    The American Journal of Human Genetics 04/1979; 31(2):95-105. · 10.99 Impact Factor
  • Transactions of the Association of American Physicians 02/1979; 92:189-95.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Formation of microaggregates in blood stored in conventional media is reflected by rapidly rising screen filtration pressure (SFP). We show that the BAGPM (bicarbonate, adenine, glucose, phosphate, and mannitol) blood preservation system maintains SFP at near normal levels throughout the storage period of 42 days. Whenever the SFP had a tendency to rise in BAGPM blood, filtration through a routine in-line blood filter reverted SFP back to baseline levels. Blood from the same donors stored in citrate-phosphate-dextrose (CPD) adenine had a rapidly rising SFP by 7 to 14 days of storage. Filtration through the routine blood filter had no effect on the SFP of blood stored in CPD-adenine, CPD, or ACD. BAGPM not only maintains adequate levels of ATP and 2,3-diphosphoglyceric acid (2,3-DPG) during full 42 days of storage but also offers a unique system in which microparticulate material is prevented from forming, with maintenance of low SFP, perhaps because of its low leukocyte, platelet, and fibrinogen content.
    Journal of Laboratory and Clinical Medicine 04/1977; 89(3):504-8. · 2.62 Impact Factor

Preview

Download
2 Downloads